Dr. Michael Brady is the Director of Microbiology Services at Toxikon Corporation. In that role, he oversees the microbiology testing for medical devices. He is the author of a number of articles and co-inventor on two antimicrobial patent applications. Dr. Brady received his BA in Biology from St. Anselm College, an MS in Biology from the University of Lowell, and a PhD in Molecular Microbiology from the University of Massachusetts Medical School. His graduate research focused on bacterial pathogenesis for a class of enteric pathogens. Prior to joining Toxikon, he conducted pre-clinical development studies for antimicrobial technologies.
Michael Brady
Director of Microbiology Services, Toxikon
